Heart Failure With Normal Ejection Fraction: Clinical Trials

3 trials for Heart Failure With Normal Ejection Fraction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown, 1 withdrawn. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 1, Unknown 1, Withdrawn 1

Follow Heart Failure With Normal Ejection Fraction: new trials by email Literature Review of Heart Failure With Normal Ejection Fraction trials Research Report on Heart Failure With Normal Ejection Fraction

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Iron Substitution With Ferric Carboxymaltose as Treatment Strategy for Heart Failure Patients With Preserved Ejection Fraction
Ferric carboxymaltose, Placebo - Heart Failure With Normal Ejection Fraction, Iron-deficiency
Phase 4WithdrawnCantonal Hospital, Baselland2021-12-012022-07-28
β-blockers Withdrawal in Patients With HFpEF and Chronotropic Incompetence: Effect on Functional Capacity (Preserve-HR)
Controlled withdrawal of beta-blockers, Cardiopulmonary Exercise Testing - Heart Failure With Normal Ejection Fraction, Chronotropic Incompetence
Phase 4CompletedFundación para la Investigación del Hospital Clínico de Valencia522018-10-012021-03-02
Inhaled Iloprost and Exercise Hemodynamics and Ventricular Performance in Heart Failure With Preserved Ejection Fraction
Iloprost, Placebo - Heart Failure With Normal Ejection Fraction
Phase 4UnknownNational Taiwan University Hospital342017-11-292019-08-14

Narrower conditions

Anemia, Iron-Deficiency (1)

Broader conditions

Anemia (1)  ·  Anemia, Hypochromic (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Iron Deficiencies (1)  ·  Iron Metabolism Disorders (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Exercise Test (1)  ·  Iloprost (1)  ·  Sodium Chloride (1)  ·  ferric carboxymaltose (1)

Sponsors

Cantonal Hospital, Baselland (1)  ·  Fundación para la Investigación del Hospital Clínico de Valencia (1)  ·  National Taiwan University Hospital (1)

Countries

Spain (1)  ·  Taiwan (1)

Top investigators

Thomas Dieterle, MD (1)

Results publications

PMID 26449137, PMID 31479003, PMID 31849715, PMID 32073676, PMID 34794685, PMID 38324280

NIH funding

2017 (1), 2018 (1)